Democratic Republic of Congo
Yves Mufike
Dr. Yves Mufike obtained his diploma in General Medicine at the University of Kinshasa in 2013. Currently, he is training at the Department of Family Medicine of the Protestant University in Congo and provides consultations in general medicine. Dr. Yves Mufike is as a clinical medical doctor with 7 years experiences in Clinical Medicine and prevention of infectious diseases, particularly neglected tropical diseases.
USA:
Connecticut
Kieran John O'Donnell
Dr. O’Donnell is an Assistant Professor in the Department of Psychiatry at McGill University. He obtained his PhD in Clinical Medicine from Imperial College London in 2011 and conducted his postdoctoral research studies at the Douglas Research Centre. He is an expert in perinatal influences on early-childhood development, and the biological embedding of early adversity. His work examines how the early environment shapes child development and combines genetic, epigenetic and epidemiological approaches to identify those at-risk for adverse mental health outcomes. He also seeks to understand the molecular mechanisms by which positive and nurturing environments mediate their positive effects on child neurodevelopment.
France:
Lyon
Behrouz Kassai
Behrouz KASSAI is a pediatric pharmacologist specializing in public health. His hospital activity is focused on the evaluation of drugs and diagnostic tests, and the implementation of their results in practice. He has 17 years of experience in the design, conduct and publication of clinical trials, translational research and meta-analyses in the field of cardiovascular disease, pediatrics and rare diseases. Assistant lecturer in the Department of Clinical Pharmacology since 1999 and at the Center for Clinical Investigation (Inserm-Hospices Civils de Lyon) since 2003, he directs the pediatric research activity, a team of 25 members. In 2016, he created the Pharmacotoxicology department at the Hospices Civils de Lyon (HCL), joining the two departments of Clinical Pharmacology and Pharmacovigilance-Antipoison Center. In 2018, he was appointed head of the new “Clinical Epidemiology” department. Deputy to the head of research activities at the Public Health Center since 2019, he drafted the scientific strategy of the Public Health Center, and research in pharmacoepidemiology at the HCL.
Sabine Mainbourg
Dr Sabine Mainbourg is a medical physician working in the Internal Medicine department at the Lyon Sud Hospital (France). She also teaches therapeutics to Claude Bernard University medical students (Lyon). In parallel, completed her PhD, studying morbi-mortality and therapeutics impact in giant cell arteritis. Interested in pharmacoepidemiology, she has started her postdoctoral training at CHU Sainte-Justine Research Center in June 2022. She will focus on the immunosuppressants exposure consequences during pregnancy funded by the Fond de Recherche Québecois – Santé.
China:
Zhengzhou
Chongjian Wang
Chongjian Wang holds a bachelor’s degree in Preventive Medicine, a master’s degree in Nutrition and Food hygiene and a Ph.D. in Epidemiology and biostatistics from the Tongji Medical College of Huazhong University of Science & Technology in China. From 2012-2013, Dr. Wang conducted postdoctoral research studies at the University of Montreal and the CHU Sainte-Justine Research Center. In 2008, Dr. Wang joined the School of Public Health at Zhengzhou University. Chongjian Wang is currently a Distinguished Professor at the Department of Epidemiology and Biostatistics at Zhengzhou University, and the Chair of the Henan Rural Cohort Study including in 39259 rural residents in China. He has authored over 200 peer-reviewed scientific papers and 9 book chapters. He aims to further scientific knowledge for the wellbeing of rural residents including in women and children both at the level of the individual patient and at the population level.
Xian Wang
Xian Wang is affiliated to the Department of Epidemiology and Biostatistics at Zhengzhou University.